Media Center
Latest News
December 10, 2014
WASHINGTON, DC – Today, U.S. Representative Michael McCaul (R-TX) introduced the Christmas Tree Tax Exclusion Act, which would exclude “choose and cut” Christmas tree producers, like the Elgin CHRISTmas Tree Farm in Texas’ 10th congressional district, from a new Obama Administration tax on Christmas trees.
Issues:Economy
December 8, 2014
WASHINGTON, DC – Today, U.S. Representative Michael McCaul (R-TX) introduced H.R. 5805, the Andrea Sloan Compassionate Use Reform and Enhancement (CURE) Act, which would make important reforms to the Food and Drug Administration’s (FDA) expanded access ("compassionate use") program, by ensuring seriously ill patients have the right to know the compassionate use policies of pharmaceutical companies. The bill is named after Andrea Sloan, an Austin resident who died on New Year's Day after being denied access to a potentially lifesaving drugs to treat her seven-year battle with ovarian cancer.
Issues:Health Care
December 4, 2014
WASHINGTON, DC – Following House passage of the language included in the FY15 National Defense Authorization Act (NDAA) that awards Purple Hearts to the victims of the 2009 Ft. Hood terrorist attack, Congressman Michael McCaul (R-TX) released the following statement.
November 20, 2014
WASHINGTON, D.C. – Today, U.S. Rep. Michael McCaul, R-Texas, chairman of the Committee on Homeland Security, released the following statement on President Obama’s proposed executive actions on immigration:
November 14, 2014
WASHINGTON, DC – Today following the passage of H.R. 5682, approving the Keystone XL Pipeline, Congressman Michael McCaul (R-TX) released the following statement.
September 19, 2014
Friends say Andrea Sloan would have loved to attend a summit this weekend in Washington, D.C., that will focus on research for childhood cancer and expanded access to experimental drugs for all cancer patients.
Sloan, 45, passed away earlier this year after a fight to gain access to an experimental drug to treat her ovarian cancer through a process called compassionate use. She was eventually granted access to a different drug made by a different company, but by then, her cancer had progressed too far.
Issues:Health Care
August 6, 2014
AUSTIN, TX – Today, following passage of landmark reforms by the Mexican Congress that will end Pemex's 75 year old monopoly on Mexico's energy industry, Congressman Michael McCaul released the following statement.
August 1, 2014
WASHINGTON, D.C. – U.S. House Homeland Security Committee Chairman Michael McCaul (R-Texas) released the following statement on the House passage of legislation to address the surge of unaccompanied children crossing the border, including a supplemental appropriations bill (H.R. 5230) and a bill to prevent the continuation or expansion of President Obama’s Deferred Action for Childhood Arrivals (DACA) program (H.R. 5272).
Issues:Border Security
July 31, 2014
Regeneron Pharmaceuticals Inc. and Sanofi SA are spending $67.5 million on a novel bet they hope will help them outflank Amgen Inc. in the race to get a new class of cholesterol drugs to the market.
The companies are paying the money to acquire a special voucher held by BioMarin Pharmaceuticals Inc. in a bid to hasten regulatory review of their drug alirocumab, one of an emerging group of medicines that lower cholesterol by targeting a gene known as PCSK9.
Issues:Health Care
July 21, 2014
WASHINGTON, DC – Today, following Governor Perry’s announcement of his intention to send up to 1,000 National Guardsmen to the border as a force multiplier and to act as a deterrent to further illegal crossings into the United States, Congressman McCaul (TX-10), Chairman of the House Homeland Security Committee, released the following statement.